Artificial Intelligence | Machine Perception | Knowledge Representation and Reasoning VariantYX | Transforming Genetic Testing


Biotechnology, Healthcare, Genomic Diagnostics, Rare diseases, Cancer Predisposition Framingham, Massachusetts, MA, United States

VariantYX

Artificial Intelligence | Machine Perception | Knowledge Representation and Reasoning


VariantYX | Transforming Genetic Testing

VariantYX

Biotechnology, Healthcare, Genomic Diagnostics, Rare diseases, Cancer Predisposition


Framingham, Massachusetts, MA, United States

Providing comprehensive genetic testing using a single method approach that is based on whole-genome sequencing

Genomic Unity testing uses a single method for the detection of multiple types of variants to provide one, unified clinical report. PCR-free whole genome sequencing is paired with in-silico analysis to identify small sequence changes, large structural variants, mitochondrial variants, and tandem repeat expansions within a single sample. A complete analysis can be ordered directly, or a more targeted analysis can be selected followed by reflexing up to the complete analysis in case no initial results are identified.

 
 

   Total Funding: $18 M

   Funding Stage: Series B

   Business Stage: Scaling Up

   Market: B2C

   Company Size: 26 to 50

   Founded: 2014

 
 
 
 
Haim Neerman


Haim Neerman
Co-Founder & CEO

Tomer Jackman


Tomer Jackman
Co-Founder & COO

Muthu Meyyappan


Muthu Meyyappan
CCO

Yaron Rachmany


Yaron Rachmany
CIO

 
 

VariantYX is growing. Want to work at VariantYX? VariantYX is hiring. Join team at VariantYX

 

View All

Assistant Quality Assurance (QA)

Framingham, Massachusetts

Software Engineer

Framingham, Massachusetts

Medical/Clinical Genetic Review Specialist – Managed Care

Framingham, Massachusetts

Clinical Variant Scientist

Framingham, Massachusetts

 
 
appengine.ai

World's Most Promising AI/ML Startups